Media center

At PATH, our global health experts are developing partnerships, new devices, and solutions to the world's most pressing health needs. Contact us to speak with one of PATH's experts today.

Contact Us

Director of Global Strategic Communications:
David Verga

Email: media@path.org

Recent Press Coverage

  1. An end-to-end look at how the Gates Foundation, PATH, and the Serum Institute of India, Pvt., Ltd., worked together to create a new pneumococcal conjugate vaccine.
    Published: April 2022
  2. PATH is named in this piece highlighting the achievement of RTS,S (the world’s first malaria vaccine) and calling for continued investment against the disease.
    Published: April 2022
  3. PATH’s Neha Agarwal and Evan Spark-DePass break down how investment frameworks can lead to more transparent and impactful investments in health.
    Published: March 2022
  4. PATH is collaborating with ministries of health and local partners to integrate mental health care into existing health services – to fill gaps and enable holistic primary care.
    Published: March 2022

We develop evidence-based expertise and resources

Our global team leverages data and evidence to develop resources and innovations that bring good health to more people.

Explore our evidence

Join the latest discussions on health equity.

We partner with the public and private sector, government, and academia from around the world to share insightful conversations on the latest topics affecting health equity.

Explore PATH events

PATH Newsroom

Related articles

Read our latest

970 Item s
970 Item s
    Date
    From
    To
  1. PATH, as a major sub-partner on the consortium led by FHI360, launches the STRengthening Infectious disease DEtection Systems (STRIDES) Activity: a new Activity funded by USAID to combat epidemics, pandemics, and novel infectious disease threats.
    Published: November 2024
    Press Release
  2. Published: October 2024
    Announcement
  3. The trial aimed to determine how well a new, injectable, non-replicating rotavirus vaccine candidate works, compared to a licensed oral rotavirus vaccine in preventing infant diarrhea.
    Published: October 2024
    Announcement
  4. Published: October 2024
    Announcement
  5. Published: October 2024
    Press Release